Skip to main content
Log in

Argumente für eine prophylaktische Therapie der okulären Hypertension

Arguments for prophylactic therapy of ocular hypertension

  • Leitthema
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

Zusammenfassung

Der erhöhte Augeninnendruck ist derzeit der einzige beeinflussbare Risikofaktor für das Glaukom. Bei einer okulären Hypertension ist zwar der Augeninnendruck erhöht, Papille und Gesichtsfeld sollen keine Schäden aufweisen. Die Abgrenzung zum Glaukom anhand der Papille lässt sich häufig nur im Verlauf treffen, weil die Schnittmenge zwischen noch normalen und bereits pathologischen Befunden groß ist. In der „Ocular Hypertension Treatment Study“ (OHTS) wurde die Effektivität einer prophylaktischen Behandlung gezeigt, in der OHTS und der „European Glaucoma Prevention Study“ (EGPS) wurden Risikofaktoren gefunden, die eine Konversion zum Glaukom begünstigen. Es handelt sich um den Augeninnendruck, die Größe der Exkavation im Vergleich zur Papillenfläche, eine geringe zentrale Hornhautdicke, die erhöhte „pattern standard deviation“ in der statischen Perimetrie und das Alter. Die prophylaktische Behandlung der okulären Hypertension sollte sich an diesen Risikofaktoren und der speziellen persönlichen Situation der Patienten orientieren und individuell abgewogen werden. Je höher der Augeninnendruck, je geringer die zentrale Hornhautdicke, je größer die Papillenexkavation und je jünger der Patient, desto eher sollte die Behandlung begonnen werden.

Abstract

Increased intraocular pressure is currently the only manipulable risk factor for glaucoma. In ocular hypertension the intraocular pressure is increased but the optic nerve head and visual field are thought to show no damage. Classification into glaucoma by means of the optic nerve head is often possible only over a period of time because there is a large overlap between the already pathological and still normal findings. In the Ocular Hypertension Treatment Study (OHTS) the effectiveness of prophylactic treatment was demonstrated. In the OHTS and the European Glaucoma Prevention Study (EGPS) risk factors have been identified, such as increased intraocular pressure, size of the excavation of the optic nerve head, decreased central corneal thickness, increased pattern standard deviation in the visual field and age. Before treatment of ocular hypertension is initiated these risk factors and the patient’s personal situation should be considered. The higher the intraocular pressure, the smaller the central corneal thickness and the larger the excavation of the optic nerve and the younger the patient, the earlier treatment should be started.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Aptel F, Denis P (2011) Risk factors of glaucoma progression: intraocular pressure fluctuations. J Fr Ophtalmol

  2. Asrani S, Zeimer R, Wilensky J et al (2000) Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 9:134–142

    Article  PubMed  CAS  Google Scholar 

  3. Bonomi L, Marchini G, Marraffa M, Morbio R (2001) The relationship between intraocular pressure and glaucoma in a defined population. Data from the Egna-Neumarkt Glaucoma Study. Ophthalmologica 215:34–38

    Article  PubMed  CAS  Google Scholar 

  4. David R, Zangwill L, Badarna M, Yassur Y (1988) Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica 197:69–74

    Article  PubMed  CAS  Google Scholar 

  5. Friedman DS, Wilson MR, Liebmann JM et al (2004) An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol 138:19–31

    Article  Google Scholar 

  6. Gordon MO, Beiser JA, Brandt JD et al (2002) The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120:714–720; discussion 829–830

    PubMed  Google Scholar 

  7. Gordon MO, Torri V, Miglior S et al (2007) Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology 114:10–19

    Article  PubMed  Google Scholar 

  8. Group AoTGSRS (2009) For which glaucoma suspects is it appropriate to initiate treatment? Ophthalmology 116:710–716

    Article  Google Scholar 

  9. Hayreh SS, Zimmerman MB, Beri M, Podhajsky P (2004) Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion. Ophthalmology 111:133–141

    Article  PubMed  Google Scholar 

  10. Heijl A, Leske MC, Bengtsson B et al (2002) Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268–1279

    PubMed  Google Scholar 

  11. Higginbotham EJ (2006) Treating ocular hypertension to reduce glaucoma risk: when to treat? Drugs 66:1033–1039

    Article  PubMed  Google Scholar 

  12. AGIS Investigators (2002) The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 134:499–512

    Article  Google Scholar 

  13. Koizumi H, Ferrara DC, Brue C, Spaide RF (2007) Central retinal vein occlusion case-control study. Am J Ophthalmol 144:858–863

    Article  PubMed  Google Scholar 

  14. Leydhecker W, Akiyama K, Neumann HG (1958) Intraocular pressure in normal human eyes. Klin Monatsbl Augenheilkd 133:662–670

    CAS  Google Scholar 

  15. Nouri-Mahdavi K, Hoffman D, Coleman AL et al (2004) Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111:1627–1635

    Article  PubMed  Google Scholar 

  16. Peeters A, Webers CA, Prins MH et al (2010) Quantifying the effect of intraocular pressure reduction on the occurrence of glaucoma. Acta Ophthalmol 88:5–11

    Article  PubMed  Google Scholar 

  17. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262–267

    Article  PubMed  CAS  Google Scholar 

  18. Quigley HA, Dunkelberger GR, Green WR (1988) Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 95:357–363

    PubMed  CAS  Google Scholar 

  19. Quigley HA, Green WR (1979) The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology 86:1803–1830

    PubMed  CAS  Google Scholar 

  20. Rochtchina E, Mitchell P (2000) Projected number of Australians with glaucoma in 2000 and 2030. Clin Experiment Ophthalmol 28:146–148

    Article  PubMed  CAS  Google Scholar 

  21. Shekelle P (2004) The appropriateness method. Med Decis Making 24:228–231

    Article  PubMed  Google Scholar 

  22. Susanna R Jr, Vessani RM (2007) New findings in the evaluation of the optic disc in glaucoma diagnosis. Curr Opin Ophthalmol 18:122–128

    Article  PubMed  Google Scholar 

  23. Weinreb RN, Zangwill LM, Jain S et al (2010) Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to the Ocular Hypertension Treatment Study. Ophthalmology 117:1674–1683

    Article  PubMed  Google Scholar 

  24. Zangwill LM, Miglior S, Hoffmann EM et al (2011) Confocal Scanning Laser Ophthalmoscopy (CSLO) to predict the onset of Primary Open Angle Glaucoma (POAG): pooled analysis of the CSLO Ancillary Study to the Ocular Hypertension Treatment Study (OHTS) and the European Glaucoma Prevention Study (EGPS). ARVO Meeting Abstracts 52:3060

    Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Wahl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wahl, J. Argumente für eine prophylaktische Therapie der okulären Hypertension. Ophthalmologe 108, 1011–1015 (2011). https://doi.org/10.1007/s00347-011-2431-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-011-2431-9

Schlüsselwörter

Keywords

Navigation